With this collaboration, Respiree's patient monitoring solution will be made available for healthcare professionals in APAC through a pilot program using Roche's blood glucose monitoring system. The goal is to simplify clinical workflows and augment diagnostic and monitoring capabilities, leading to improved patient outcomes.
SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- Existing patient monitoring workflows often rely on nurses managing patients from centralized workstations, monitoring vitals and biomarkers at different intervals, and manually collecting vitals. This process can be inefficient, especially with limited workstations, multiple workflows, increased patient volumes, and nursing shortages.
By the first quarter of 2025, Respiree will team up with Roche to launch pilot programs across APAC that offer a simplified approach to patient monitoring by combining Roche's cobas® pulse system with Respiree's vital sign monitoring. The solution is also expected in future to integrate machine learning models that predict clinical deterioration using historical data with risk scores at the bedside.
The cobas® pulse system, a point of care device, equipped with digital health applications based on the Android operating system allows for real-time administration and visualization, eliminating the need for centralized workstations. Respiree's solution measures multiple biometrics, including pulse rate, oxygen saturation, respiratory rate, temperature, tidal depth, inhalation-to-exhalation ratios, and has the capability to input blood pressure measurements.
With the use of Respiree and cobas® pulse solutions, healthcare professionals can register patients to Respiree's connected devices in real-time, monitor historical data and potential deterioration directly at the patient's bedside without needing to return to workstations or medical carts, as well as simultaneously measure vital signs and blood sugar. They can annotate clinical notes on the Respiree solution in the cobas® pulse system.
"The use of Respiree with the cobas® pulse system has tremendous potential to enhance clinical workflows. Nurses can administer devices and view historical vitals in real-time without the need for centralized workstations, providing immediate bedside insights into patient progress. Additionally, nurses can automate the extraction and measurement of vitals from connected devices almost instantaneously, removing the need for manual scanning and measurements," says Dr. Gurpreet Singh, CEO and Founder of Respiree.
About Respiree
Respiree is an AI/ML health tech company building clinically-validated AI for managing disease progression. Respiree is CE marked and has received regulatory clearances from the Therapeutic Goods Administration and the United States Food and Drug Administration (FDA).
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring
79th Festival de Cannes • Spotlight on Chinese Cinema • China Pavilion
CANNES, France, May 21, 2026 /PRNewswire/ -- On May 14 (local time), the Chinese film My World Without Me, directed by Tian Hairong, was screened at the Palais des Festivals in Cannes. Selected for the International Promotional Screening Unit of the 79th Festival de Cannes, the film garnered warm applause and high praise from audiences around the world, as well as invaluable feedback and insights.
Following the screening, the film's creative team joined a themed panel at the China Pavilion titled "The Power of Images and Care for the Soul," engaging in a heartfelt dialogue with filmmakers and audiences from across the globe on the themes of life and adversity — resonating deeply with the tender hearts of people from all cultural backgrounds. The panel was hosted by China Film Foundation & China Film Association and organized by China Film Foundation • Wutianming Film Fund.
About the Film and Its Creative Team
My World Without Me is directed and headlined by Tian Hairong, with Zhang Hanyu serving as executive producer for the first time. The film was crafted over nearly seven years with exceptional care and dedication. It focuses on the contemporary community of people with hidden depression, conveying love and hope through the quiet spaces of daily life and the gentle light found in ordinary moments. Confronting suffering head-on, the film exemplifies the restrained aesthetics and humanistic warmth characteristic of Chinese realist cinema, offering an Eastern perspective on mental health narratives.
Tian Hairong is a graduate of the Performance Department of the Shanghai Theatre Academy and a renowned actress and producer in mainland China. She received the Golden Deer Award for Best Actress at the Changchun International Film Festival for Romantic Girl, the Best Actress award at the Nordic International Film Festival for The Spirit of a Generation: Tang Qunying, and the Best Supporting Actress award at the 12th Macao International Film Festival. Tian expressed her hope that through international platforms such as Cannes, the world will come to feel the warmth and depth of Chinese cinema.
International Recognition
French director Frédéric Oberlin praised the film for using a uniquely Eastern mastery of emotion to deliver silent feelings directly to the heart. Sinologist Luisa Prudentino noted after viewing the film that its sincere emotional core transcends cultural barriers, protecting the dignity of life and becoming a warm thread of empathy connecting different civilizations.
The film is set to continue participating in further international film festivals, using the power of cinema to build bridges of cultural communication and to help Chinese stories reach the world in a manner rich with humanistic care.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Touching Hearts Through Cinema -- Chinese Film "My World Without Me" Earns High Praise at Cannes
